Pityriasis Rosea: Who named it ?
Désolé, cet article est seulement disponible en English.
Tout afficher Заболевания кожи (состояния кожи)Заболевания, передающиеся половым путем (ЗППП) или инфекции (ИППП)ЛечениеНарушения пигментацииОсновные депигментирующие веществаПигментация, гиперпигментация и решения従来の脱色剤 性感染症（STD）汉语治療 漢語皮膚病色素沈着、色素沈着過剰症と解決策色素異常症Acnéallemand (Deutsch)Application topiquearabe (العربية)Article of the weekArticlesBehandlungenchinois (中文)Collection de livres anciens de dermatologieCongrèsCrèmes-pommades-lotions à appliquer sur la peauCysteamine Crème DépigmentanteDébut de problèmes de peau en fonction de l'âgeDermatologie dans les maladies infectieusesDermatologie dans les maladies systémiquesDistribution géographique des visitesDisturbi della pigmentazioneDistúrbios da pigmentaçãoDoenças Sexualmente Transmissíveis – DSTDoenças de peleEducationEnfermedades de la pielEnfermedades de Transmisión SexualEpilation au laserespagnol (Español)Explication de traitements pour le patientFréquence des problèmes de peauGroupes d'entraide et AssociationsGroupes d'entraide et AssociationsAvis de prise en chargeHauterkrankungenInfections sexuellement transmissiblesLes kératoses séborrhéiques (verrues séborréiques)(verrues séniles)(taches de vieillesse)Traitements dermatologiquesTraitements esthétiquesInformations GénéralesInjection de toxine botulique, d'acide hyaluronique et peelingsitalien (Italiano)japonais (日本語)La lèpre (maladie de Hansen)L'alcool et la peau (éthylisme)Le cholestérol et la peauLe mésothéliome et la peauLes compagnies lasers et leurs appareils médicaux utilisés en dermatologieLes laboratoires cosmétiquesLes laboratoires pharmaceutiques et leurs médicaments utilisés en dermatologieLiens académiquesL'Industrie au service de la DermatologieMaladies de peauMaladies Sexuellement Transmissibles (MST) - Un GuideMalattie della pelleMalattie trasmissibili sessualmente – MTSMédicaments à prendre par la boucheMga PaggamotMga Pekas, Pagdidilim Ng Kulay Ng Balat At Mga SolusyonMga Sakit Na Nakukuha Sa PagtatalikMga Sakit Sa BalatNatural productsNon classéNotes de congrès/conférencesPagkabagabag Sa Kulay Ng BalatPigmentação, hiperpigmentação e soluçõesPigmentación, hiperpigmentación y solucionesPigmentation, hyperpigmentation et ses solutionsPigmentazione, iperpigmentazione e soluzioniPigmentierung, Hyperpigmentierung und LösungenPigmentstörungenPolémiquePoliticiensportugais (Português)Präsentation von Globale DermatologiePrédilection de problèmes de peau en fonction du sexePresentación del Globale DermatologiePrésentationsPresentazione di Globale DermatologieProdotti depigmentanti "tradizionali"Productos despigmentantes “tradicionales”Produits dépigmentants "traditionnels"Produtos despigmentantes "tradicionais"Professionnelsrusse (русский язык)Sexuell übertragbare Krankheiten (STD)Stars de CinémaSujets dermatologiques spécialisésSujets dans d'autres languesTélédermatologieHistoire & TerminologieTokelau (Dermatophytose imbriquée)Tradisyonal Na Produktong PampaputiTraditionelle depigmentierende SubstanzenTraducteur de langage dermatologique médicalTraitements non-médicamenteuxTraitements par le LaserTraitements physiquesTrastornos de la pigmentaciónTratamentoTratamientoTrattamentoTroubles de la pigmentationVIPsVoie orale
Syphilis – How was the cause found ?
Désolé, cet article est seulement disponible en English.
Hidradenitis Suppurativa (Acne Inversa): More evidence on how to treat it
Epidemiology of Hidradenitis suppurativa (HS) also called Acne Inversa (Jemec) -Prevalence is anywhere between 0.0033% (genetic hypothesis) to 4% (self reporting in nurses) -In a big study in immigrants comparing with Spanish citizens, prevalence of HS was found to reach 0.2% up to 0.9% in Spanish citizens. prevalence is anywhere between 0.0033% (genetic hypothesis) to…
DetailsErythrodermic Psoriasis Treatment with Ustekinumab
Erythrodermic psoriasis (EP) is a generalized, inflammatory erythematous dermatosis, with or without exfoliation lasting for at least 3 months involving 75% or more of the body surface Methods: In this retrospective study PASI evaluation was done at 4, 16 and 28 weeks of treatment 22 patients dosage of 45mg in 16 patients dosage of 90mg…
DetailsBrodalumub: also effective against Nail and Scalp Psoriasis
Brodalumab (KHK4827, also known as AMG827) is a monoclonal antibody that binds to human IL-17RA and blocks the biological activities of IL-17A, 17F, 17A/F and IL-17E It has been shown to improve plaque psoriasis and psoriatic arthritis in 12 weeks. Goal: efficacy of KHK4827 for nail nail and scalp psoriasis in Japanese patients with moderate…
DetailsThe Benefits of Sunscreens: Protective Cellular Effects from Ultraviolet A Rays
Lipofucsin is the intracellular aggregate of oxidized proteins and lipids. It is a marker of autophagy and is stainable on immunochemistry with Sudan Black B (SBB) Ultraviolet A (UVA) damage induces DNA damage, oxidation of proteins and lipids, autophagy and subsequently apoptosis (provided exposure is long enough) In this study human cultures of fibroblasts were…
DetailsPalmoplantar Psoriasis Treatment with Ustekinumab
Introduction: Palmoplantar psoriasis presents as sterile pustules with hyperkeratosis, erythema, scaling and fissuring on the palms and soles Treatment is challenging. topicals don’t really work and acitretin is not always effective. Methodology: prospective study 9 patients, mean age 48 years old ustekinumab administered subcutaneously at weeks 0,4 and then every 12 weeks evaluation with PPPASI…
DetailsPRP to treat Vitiligo ?
PRP is an autologous platelet concentrate in a small volume of plasma obtained from high speed centrifugation of the patient blood sample Methods 26 patients with vitiligo (type and location not specified) Intradermal intralesional PRP injection was done every 2 weeks until a response was observed or improvement was seenscoring with the Vitiligo European task…
DetailsAdalimumab vs Etanercept in Quality of Life Improvement
Adalimumab showed a slightly higher reduction in PASI after 1 year, however it proved an equivalent efficacy to Etanercept after an extensive follow-up (up to 5 years) Contrarily to etanercept, adalimumab patients showed a progressive improvement with DLQI (84 to 77) For both groups, sustained response (PASI75 maintenance of results 60 months after initiation of…
DetailsBiologic Therapy for Psoriasis: Paradoxical Reactivation of Psoriasis on Infliximab
Désolé, cet article est seulement disponible en English.